MorphoSys AG (NASDAQ:MOR) Sees Large Drop in Short Interest

MorphoSys AG (NASDAQ:MOR – Get Rating) was the target of a large decline in short interest during the month of April. As of April 15th, there was short interest totalling 28,700 shares, a decline of 13.3% from the March 31st total of 33,100 shares. Based on an average daily volume of 111,400 shares, the short-interest […]

Related Keywords

, Citadel Advisors , Virtu Financial , Alphacentric Advisors , Morgan Stanley , T Rowe Price Investment Management Inc , Jpmorgan Chase Co , Get Rating , Capital Management , Centric Advisors , Price Investment Management , Morphosys Daily , Morphosys , Nasdaq Mor , Humor , Medical , Stocks , Options , Put , Call ,